NCT00486902View on ClinicalTrials.gov

Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?

NACompletedINTERVENTIONAL

Enrollment

188

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Ketamine Adverse ReactionEffects of; Anesthesia, Spinal and Epidural, in PregnancyComplication of Labor and/or Delivery

Interventions

DRUG

Ketamine

Ketamine 10 mg diluted to 20 mL delivered over 10 minutes via an infusion pump set at 2ml/minute

DRUG

Placebo

Saline 20 mL IV infusion delivered over 10 minutes via an infusion pump set at 2ml/minute

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors

lead

Northwestern University

OTHER

NCT00486902 - Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients? | Biotech Hunter | Biotech Hunter